Wegovy Lowers Risk of Stroke and Heart Attack, Drugmaker Says
Weight loss drug Wegovy cuts risk of heart attack and stroke by 20%, according to a Novo Nordisk trial. Experts explain the study’s findings.
Source: prevention.com
Page 19 - Structural Heart Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Structural Heart Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Structural Heart Program Today - Breaking & Trending Today
Hypertension: How just 1 alcohol drink a day may affect blood pressure
A study found alcohol consumption is linked to increased systolic blood pressure, even at low levels of alcohol consumption such as one drink per day.
Source: medicalnewstoday.com
Anteris Technologies' DurAVR heart valve used in life-saving valve-in-valve procedure
The flagship transcatheter heart valve of Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has been successfully implanted during a valve-in-valve procedure as...
Source: proactiveinvestors.com.au
Anteris Technologies Announces First Successful Implantation of DurAVR THV in a Valve-in-Valve Procedure
31.07.2023 - Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve shaped to mimic ... Seite 1
Source: wallstreet-online.de
Anteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedure
BRISBANE, Australia & MINNEAPOLIS, July 31, 2023--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart valve and the world’s only balloon-expandable, single-piece transcatheter aortic valve shaped to mimic the performance of a native human aortic valve, announces that the DurAVR™ THV was used for the first time in a valve-in-valve (ViV) procedure as part of Health Canada’s Special Access Program (SAP).
Source: yahoo.com